Summer
holiday. A mere 10 articles this month!
1)
Community pharmacist knowledge, attitudes and
confidence regarding naloxone for overdosereversal.
Nielsen S, Menon N,
Larney S, Farrell M, Degenhardt L.
Addiction. 2016 Jul 1.
doi: 10.1111/add.13517. [Epub ahead of print]
Comment: Most
pharmacists in Australia would provide naloxone, but a minority feel
comfortable selecting patients and educating about naloxone use and overdose.
Coffin PO, Behar E, Rowe
C, Santos GM, Coffa D, Bald M, Vittinghoff E.
Ann Intern Med. 2016 Jun
28. doi: 10.7326/M15-2771. [Epub ahead of print]
Comment: Naloxone can
be successfully prescribed to primary care patients on longterm opioids for
chronic pain, and receipt of naloxone is associated with a remarkable reduction
in opioid-related emergency department visits.
Sharma B, Bruner A,
Barnett G, Fishman M.
Child Adolesc Psychiatr
Clin N Am. 2016 Jul;25(3):473-87. doi: 10.1016/j.chc.2016.03.002. Epub 2016 Apr
9. Review.
Comment: Review of
opioid use disorder and treatments.
Ambrose G, Amlani A,
Buxton JA.
BMJ Open. 2016 Jun
21;6(6):e011224. doi: 10.1136/bmjopen-2016-011224.
Comment: Respondents
administering naloxone to overdoses on the street were more likely to call for
medical assistance than those doing so in a private residence. This makes a lot
of sense. Imaging if giving a breathing treatment for asthma in a home versus
on the street – the latter setting is more likely to result in seeking
assistance.